col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

430 Results       Page 1

Elsevier: Value in Health
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―25 Disability-Adjusted Life Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United States Qiushi Chen, Paul M. Griffin, Sarah S. Kawasaki
2 [GO] 2022―Oct―01 The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis Stacey Kowal, Carmen D. Ng, Robert Schuldt, Daniel Sheinson, Richard Cookson
3 [GO] 2022―Aug―11 Modeling the Recovery of Elective Waiting Lists Following COVID-19: Scenario Projections for England Nicholas C. Howlett, Richard M. Wood
4 [GO] 2022―Jul―20 Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: Correspondence Pathum Sookarodee, Viroj Wiwanitkit
5 [GO] 2022―Jun―25 PCR80 Informing a Conceptual Framework for a Patient-Centered Value Assessment of Emerging Therapies for Mild/Moderate COVID-19 C Ali, TJ Mattingly, JF Slejko, S Dosreis
6 [GO] 2022―Jun―25 OP6 Measuring and Quantifying Lost Productivity Due to Priority Diseases: A Review of the Past 10 Years and Reflections on the Unprecedented Changes and Implications Emerging with COVID-19 S Rojanasarot, NC Edwards, SK Bhattacharyya
7 [GO] 2022―Jun―25 MSR10 An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19 M Broder, SN Gibbs, I Yermilov
8 [GO] 2022―Jun―25 HSD54 Adherence to Expert Recommendations: Evidence from Oral vs. Infusion Substitution during COVID-19 Y Civelek, D Cullen, D Debono, MJ Fisch, J Barron, G Sylwestrzak
9 [GO] 2022―Jun―25 HSD49 Variability in Incidence of Circulatory and Endocrinal Complications Post COVID-19 S Choudhary, A Sethi, V Verma, L Brooks, M Sulzicki, S Pandey, et al. (+7)
10 [GO] 2022―Jun―25 CO67 Predictors of Long COVID in Patients with Severe COVID-19 - a US Healthcare Database Analysis C Holy, B Patterson, J Ruppenkamp, F Richards, R Debnath, JK DeMartino, et al. (+3)
11 [GO] 2022―Jun―25 EE422 Healthcare Costs Associated with Severe VS Moderate and Mild COVID-19 - a US Payer Perspective C Holy, B Patterson, J Ruppenkamp, F Richards, R Debnath, JK DeMartino, et al. (+3)
12 [GO] 2022―Jun―25 EE468 Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries J Shafrin, A Mubayi, K Birch, N Land, M Sotak, M Venkatachalam, et al. (+2)
13 [GO] 2022―Jun―25 EPH32 Perceived Risk of COVID-19 and Its Association with Preparedness and Preventive Practices: A Latent Class Segmentation Analysis O Mgbere, S Iloanusi, I Yunusa, NJR Iloanusi, S Gohil, EJ Essien
14 [GO] 2022―Jun―25 EE20 An Overview of Optimisation Studies on COVID-19 and Its Economic Benefits in India E Harika, M Roy
15 [GO] 2022―Jun―25 CO132 Duration of COVID-19 and Long COVID - a US Healthcare Database Analysis B Patterson, J Ruppenkamp, F Richards, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
16 [GO] 2022―Jun―25 EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports Z Alqahtani, JJ Guo, PR Wigle
17 [GO] 2022―Jun―25 HPR2 COVID-19 and the Use of Antenatal Care Services in Côte d'Ivoire, an Africa South of the Sahara's Country AR Attia-Konan, DFR Meless, K Koffi, J Kouame, MF Male, AS Pongathie
18 [GO] 2022―Jun―25 EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China D Zhou, T Shao, H Shao, Y Tu, Y Tang, J Zhou, et al. (+2)
19 [GO] 2022―Jun―25 CO146 Readmission and Mortality Following Discharge from Inpatient Treatment for COVID-19 By Mechanical Ventilation Status in Early and Late Phases of the Pandemic J Best, SV Mohan, J Jonas, L Arader, J Yeh, MJ Butler
20 [GO] 2022―Jun―25 EPH22 Prevalence and Risk Factors of Post COVID-19 Condition in Previously Hospitalized Patients in Bolivar, Colombia: An Observational Study A Lozano, F Salcedo Mejía, N Alvis Zakzuk, JC Fernandez Mercado, M Jerez Arias, J Zakzuk Sierra, et al. (+2)
21 [GO] 2022―Jun―25 EE471 Valuing the Fear of COVID-19 Contagion N Poudel, S AlMahasis, S Simpson, S Ngorsuraches
22 [GO] 2022―Jun―25 EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital LA Oliveira, R Lucchetta, F Tonin, AF Bonetti, HH Borba, A Matoso Mendes, et al. (+3)
23 [GO] 2022―Jun―25 EPH58 The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala J Kochuparambil, A Issac
24 [GO] 2022―Jun―25 PCR93 Comprehensibility and Usability of an Electronic COVID-19 Daily Symptom Diary K Baranov, C Casstevens, P McLeroth, E Merikle
25 [GO] 2022―Jun―25 EPH134 Sex-Gender Differences in COVID-19 Diagnosis, Hospitalization and Mortality S Kharroubi, M El Harakeh
26 [GO] 2022―Jun―25 P36 The Impact of COVID-19 Diagnosis on Healthcare Costs C. Morrow, RM. McKenna, L. Palmer
27 [GO] 2022―Jun―25 PCR158 Hungarians' Attitudes Toward the COVID-19 Disease and Vaccination: An Online Survey H Khatatbeh, M Zrínyi, R Vajda, Z Verzár, J Turcsán, K Takács, et al. (+3)
28 [GO] 2022―Jun―25 EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic A Tebaibia, A Mammeri, H Brahimi, M Ammi, N AitSaid, M Lebdjiri, et al. (+14)
29 [GO] 2022―Jun―25 EPH31 Disparities and Trends of COVID-19 Epidemiology in EU-5 Countries across Pandemic Waves: A Targeted Literature Review (TLR) S Kamra, J Venkateswara Rao, R Mandlik, S Dabral, R Pagidigummula, R Hyderboini, et al. (+3)
30 [GO] 2022―Jun―25 CO31 Health Equity Considerations in Minority Groups with Type 1 and 2 Diabetes in the COVID-19 Era: Care Utilizations and Costs Y Ionova, L Zhong, Y Ma, L Wilson
31 [GO] 2022―Jun―25 PCR100 COVID-19 Experiences of Pregnant and Postpartum Persons and Their Impact on Health-Related Quality-of-Life P Aytha Swathi, A Regan, NY Gu, M Nosek
32 [GO] 2022―Jun―25 MT30 Learnings from DTC Launch of a Digital Therapeutic for ADHD in Response to the COVID-19 FDA Policy for Digital Health Devices for the Treatment of Psychiatric Disorders L Palko
33 [GO] 2022―Jun―25 HTA56 COVID-19 from the Perspective of Intellectual Property CR Pereira da Veiga, C Da Veiga, R Arcaro
34 [GO] 2022―Jun―25 EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia R Montejano, F Riera, C Falistocco, L Espinoza, A Azamar-Alonso
35 [GO] 2022―Jun―25 EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network K Moll, S Hobbi, CK Zhou, K Fingar, T Burrell, V Hernandez-Medina, et al. (+5)
36 [GO] 2022―Jun―25 EPH135 The Effect of Lockdown on Reducing Hospitalisations Associated with COVID-19 in Australia S Choi, H Kim
37 [GO] 2022―Jun―25 HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil R Arcaro, C Da Veiga, CR Pereira da Veiga
38 [GO] 2022―Jun―25 RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD) A Kolbin, GI Syraeva, SA Mishinova
39 [GO] 2022―Jun―25 EE495 Threshold Price in the US to Achieve Cost-Effective Use of Molnupiravir and PF-07321332/Ritonavir for the Prevention of Severe COVID-19 in High-Risk Adults T Majda, D Veenstra
40 [GO] 2022―Jun―25 EPH51 Associations between Psychiatric Disorders and COVID-19 in Japan: Results from the Life Study F Murata, M Maeda, H Fukuda
41 [GO] 2022―Jun―25 EE99 Economic Burden of COVID-19 in Mexico AE Frias Gasga, VU Delgadillo Hernández, H Soto Molina, S Guzman Vazquez
42 [GO] 2022―Jun―25 EE335 The Hospitalization Burden of COVID-19 in Patients with NSCLC: Differential Impact of Vaccination F Richy, D Kumar, D Kulkarni
43 [GO] 2022―Jun―25 EE467 Recovid Study. Cost-Effectivness Analysis of Using Nutridrink 200 ML in the Treatment of COVID-19 in the Hospital M Frolov
44 [GO] 2022―Jun―25 PCR77 Using Twitter to Examine Public Perceptions about COVID-19 in the United States: A Sentiment Analysis AA Ali, K Adjei, S Fatimah, K Ezendu, M Taeb, H Chi, et al. (+2)
45 [GO] 2022―Jun―25 EE225 Economic and Clinical Impact of a Novel, Antiviral Therapy on COVID-19 in the US S Gibson, R Saunders, N Stasko, C Brown-Bickerstaff, J Oakley, M Osterman, et al. (+4)
46 [GO] 2022―Jun―25 P60 The Association between Statin Use and Severe Outcomes in COVID-19 Infected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, E. Pittman, S. Ramachandran, J. Bentley, B. Banahan, T. Kirby, et al. (+2)
47 [GO] 2022―Jun―25 EE330 Spill-over of Medical Cost for Blue Cross and Blue Shield of Louisiana Members with Differing Severity of COVID-19 Infection E Lucas, S Palanki, M Liu, D Barfield, Y Zhang, B Vicidomina, et al. (+2)
48 [GO] 2022―Jun―25 EPH20 Does a Mother's Previous Experience with COVID-19 Infection Change Her Intention to Vaccinate Her Children M Zakeri, J Li, EJ Essien, SS Sansgiry
49 [GO] 2022―Jun―25 P35 Risk of Psychiatric and Neurological Sequelae after the COVID-19 Infection: A Retrospective Cohort Study Using Claim Data A. Gaur, I. Kukreja, N. Mishra, A. Roy, A. Chopra, A. Gupta, et al. (+6)
50 [GO] 2022―Jun―25 P34 Identifying Interventions That Reduced COVID-19 Mortality in Long-Term Care Facilities: A Causal Inference Analysis R. Goldberg
51 [GO] 2022―Jun―25 CO139 Use of Remdesivir Among Hospitalized Patients with Severe COVID-19: Analysis of Electronic Health Records from Trinetx COVID-19 Network F Wolde, L Gressler
52 [GO] 2022―Jun―25 RWD69 The Impact of COVID-19 on Colorectal Cancer Screening in Northern Ireland Z Waller, E McFerran, F Lamrock, M Lawler, F Bannon
53 [GO] 2022―Jun―25 SA43 The Impact of COVID-19 on Managing Clinical Trials PP Gannavarapu, KV Mandello
54 [GO] 2022―Jun―25 SA34 Impact of COVID-19 on Telehealth Utilization: Analysis of Komodo Healthcare Map™ Claims Data A Silber, R Liu, M Mulrooney, M Salkar, K Francis, N Hadker
55 [GO] 2022―Jun―25 HSD64 The Influence of COVID-19 on Telemedicine Services Among Blue Cross and Blue Shield of Louisiana Members with Diabetes H Zhang, E Lucas, M Kiggans, Y Zhang, B Vicidomina, S Mills, S Nigam
56 [GO] 2022―Jun―25 MSR49 Assessing the Impact of COVID-19 on the Healthcare Resource Utilization and Treatment in High Incidence Oncological Conditions K Paul, V Verma, U Parashar, L Brooks, M Sulzicki, S Pandey, et al. (+7)
57 [GO] 2022―Jun―25 RWD70 Impact of COVID-19 on the Utilization of Behavioral Healthcare Services in the US I Kukreja, N Mishra, A Gaur, A Roy, A Chopra, A Gupta, et al. (+6)
58 [GO] 2022―Jun―25 RWD134 Impact of COVID-19 on the Utilization of Screening and Therapy Services for Children with Autism in the US N Mishra, M Rawat, A Gaur, I Kukreja, A Roy, A Chopra, et al. (+7)
59 [GO] 2022―Jun―25 EPH129 Blue Cross and Blue Shield of Louisiana's COVID-19 Outbreak Simulation- Deterministic SEIR Modeling M Cong, J Holloway, M Liu, E Lucas, Y Zhang, J Ouyang, et al. (+2)
60 [GO] 2022―Jun―25 EPH45 The Impact of Gingivitis and Periodontitis on COVID-19 Outcomes: A Case-Control Study C Morrow, RM McKenna, E Gebauer, L Palmer
61 [GO] 2022―Jun―25 HPR55 How Inequities and Disparities in Health & Healthcare Are Impacting COVID-19 Outcomes: A Scoping Review KJ Craig, TJ Bright, H Karunakaram, C VanHouten, Y Akdas, I Dankwa-Mullan
62 [GO] 2022―Jun―25 PCR103 A Digitally Enabled Care and Real World Evidence (RWE) Research Program Among Individuals with Asthma and COPD during the COVID-19 Pandemic R Willmon, O George, S Selvarajah, J Adams, G Soyao, M Hart, et al. (+2)
63 [GO] 2022―Jun―25 OP8 Trends in General Surgery Procedure Volumes By Modality during the COVID-19 Pandemic S Wing, A de Groot, Y Liu, Y Li
64 [GO] 2022―Jun―25 HSD47 Malignant Surgical Volumes and Length of Stay By Modality during the COVID-19 Pandemic S Wing, A de Groot, Y Liu, Y Li
65 [GO] 2022―Jun―25 EPH160 Burden of Frequent Mental Distress in the US Population during the COVID-19 Pandemic NHK Le
66 [GO] 2022―Jun―25 EPH117 Factors Associated with Receipt of Second Dose of mRNA-1273 Vaccine at Walgreens Pharmacies during the COVID-19 Pandemic E Roberts, A Shah, R Smith-Ray, P Buck, N Van de Velde, C Talarico, et al. (+2)
67 [GO] 2022―Jun―25 EPH35 Information Seeking and Preventive Behavior during the COVID-19 Pandemic T Park, I Ju, J Ohs, A Hinsley, J Muzumdar
68 [GO] 2022―Jun―25 PCR15 The Impact of the COVID-19 Pandemic and Lockdowns on the Health-Related Quality of Life of People Living with Multiple Sclerosis in Australia G Henson, I van der Mei, BV Taylor, P Blacklow, SB Claflin, AJ Palmer, et al. (+2)
69 [GO] 2022―Jun―25 EPH92 Investigating Undergraduate Students’ Perception on COVID-19 Pandemic and Social Distance and Its Influencing Factors By Association Analysis and Sentimental Analysis K Lee, S Han, L Osipenko, HS Suh
70 [GO] 2022―Jun―25 HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers? É Gaudette, Y Zhang
71 [GO] 2022―Jun―25 PCR64 COVID-19 Pandemic Effect Estimation, in Medical Attention on Patients with Gynecological Cancer and Their Caregivers in Mexico F Morales, S Guzmán Vázquez, K Torres Méndez, H Soto
72 [GO] 2022―Jun―25 HSD88 Fruit and Vegetable Consumption in Hungary during the Fall of COVID-19 Pandemic in 2020 B Tisza, T Stromájer-Rácz, Z Verzár, I Boncz, A Pakai, A Gubicskóné Kisbenedek
73 [GO] 2022―Jun―25 HTA2 RAPID C-19: Achievements and Challenges of a Collaborative Response to the COVID-19 Pandemic in the UK A Greenwood, A Brett, N Umeweni, S Upadhyaya
74 [GO] 2022―Jun―25 MSR29 Predicting Panel Attrition in Longitudinal HRQoL Surveys during the COVID-19 Pandemic in the US T Yu, J Chen, NY Gu, JW Hay, CL Gong
75 [GO] 2022―Jun―25 CO136 COVID-19 Pandemic Indirect Impact on Mortality Rates D Araja
76 [GO] 2022―Jun―25 EPH43 Impact of COVID-19 Pandemic on Cancer Preventive Screening D Weeraratne, A Rajmane, M Patel, B Rosario
77 [GO] 2022―Jun―25 HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients Y Shao, L Shi, E Nauman, E Price-Haywood, C Stoecker
78 [GO] 2022―Jun―25 HSD98 Estimating the Impact of the COVID-19 Pandemic on Healthcare Waiting Lists in England R King, A Pijper, A Marsland, R Sloan, S Holloway, B Bray, J Pearson-Stuttard
79 [GO] 2022―Jun―25 HSD19 Impact of Coronavirus Disease (COVID-19) Pandemic on Non-COVID Healthcare Utilization in Saudi Arabia R Alameddine, Y Bassil, J Barhoun, K Asmar, C Maskineh, H Al-Omar
80 [GO] 2022―Jun―25 HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia Z Liu, CA Patel, A Campbell, A Fu, C Benson
81 [GO] 2022―Jun―25 P33 Evaluating the Impact of the COVID-19 Pandemic on the Diagnosis and Staging of New Breast Cancer Cases: A Retrospective Analysis of Medical Chart Data from the United States R. Knapp, F. Hardtstock, T. Wilke, B. Boner, C. Hurmiz, A. McCracken
82 [GO] 2022―Jun―25 RWD26 Real World Evidence for the Impact of COVID-19 Pandemic on the Incidence of Multiple Myeloma in Germany S Schilling, G Azarias, L Merker, K Strobel, S Wischlen, L Kellermann
83 [GO] 2022―Jun―25 RWD117 Impact of COVID-19 Pandemic on the Romanian Breast Cancer Burden: A County Population-Based Study A Turcu-Stiolica, MS Subtirelu, M Bogdan, VC Dinescu, V Gheorman, M Aldea, et al. (+2)
84 [GO] 2022―Jun―25 EPH86 Effect of the COVID-19 Pandemic on the Utilization of Hospice-Palliative Care Services in Hungary M Lukács, A Siket, M Zrínyi, I Karácsony, I Boncz, A Pakai
85 [GO] 2022―Jun―25 CO109 Increase in All-Cause Mortality Rate for Patients Admitted to the Emergency Department (ED) with Myocardial Infarcts during COVID-19 Pandemic Regardless of ST Elevation A Braendle, K Lodaya, X Zhang, J Lilley, S Munson, F D'Souza
86 [GO] 2022―Jun―25 PCR116 Exploring the Known-Group Validity between EQ-5D-5L and GAD-7 during Hong Kong COVID-19 Pandemic Situation CW Ng, E Wong, AWL Cheung
87 [GO] 2022―Jun―25 PCR16 Stroke Rehabilitation Treatment Preferences of Chinese Physicians and Patients during the COVID-19 Pandemic: A Discrete Choice Experiment G Feng, D Hao, T Liu, X Fang, N Yan, Q Chen, et al. (+6)
88 [GO] 2022―Jun―25 EPH100 Assessment of Psychological Responses of the Indian Population Due to COVID-19 Pandemic: A Web-Based Survey RV Rajesh, A Anand, J Sebastian, J Lucca
89 [GO] 2022―Jun―25 SA44 Trends in Medication Error Reporting during the COVID-19 Pandemic: An Analysis of Faers Data, 2016 to 2021 V Wysocki, DW Grabe, PD Meek
90 [GO] 2022―Jun―25 EPH6 Health-Related Quality of Life (HRQOL) Among Chinese Population during the COVID-19 Pandemic: The Role of Socio-Demographic Factors and Loneliness E Wong, J Li, S Yuen, AHY Lai, AWL Cheung, PSY Yau, EK Yeoh
91 [GO] 2022―Jun―25 RWD31 Comparison of Remdesivir As Monotherapy or in Combination with Steroids in Treating COVID-19 Patients M Rawat, S Choudhary, A Gaur, V Verma, I Kukreja, A Roy, et al. (+7)
92 [GO] 2022―Jun―25 EPH40 Characteristics of COVID-19 Patients Admitted to the University Hospital of El Biar in Algiers during the First 6 Months of the Epidemic in Algeria: Descriptive Study of 1008 Cases A Tebaibia, A Mammeri, H Brahimi, M Ammi, N AitSaid, M Lebdjiri, et al. (+14)
93 [GO] 2022―Jun―25 PCR55 Analyzing the Relationship between Social Determinants of Health (SDOH) on Hospital Capacity for COVID-19 Patients By Geographic Region K Watkins, S Strickland, K Prudyus, K Rademacher
94 [GO] 2022―Jun―25 HSD104 Antibiotics Dispensed at Drugstores for Mild Cases of COVID-19 Patients in Northern Punjab, Pakistan U Malik, F Hashmi, N Atif, F Khan, Y Fang
95 [GO] 2022―Jun―25 EE349 Remdesivir Use in Hospitalized COVID-19 Patients in the United Arab Emirates: A Cost-Effectiveness and Health Care Resource Use Model A Subhi, A Mohamed El Shamy, SA Hussein, J Jarrett, S Kozma, C Harfouche, MA Sara Ahmad
96 [GO] 2022―Jun―25 RWD16 Impact of COVID-19 Vaccination in Reducing Average Length of Stay in Hospitals Among COVID-19 Patients in the US - a Retrospective Study from De-Identified Administrative Claims Database N Pandey, V Verma, A Chopra, I Kukreja, A Gaur, M Sulzicki, et al. (+6)
97 [GO] 2022―Jun―25 EPH132 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the US: How Did It Change in 2021 from ALPHA to DELTA Variant? R Moon, N Rosenthal
98 [GO] 2022―Jun―25 EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community A Metry, R Rafia, A Wailoo
99 [GO] 2022―Jun―25 EE415 Spatial Cost-Efficiency Analysis on the Separability Condition of COVID-19 Potential Determinants T Nepomuceno, A De Lima
100 [GO] 2022―Jun―25 SA6 A Review of Economic Evaluation on Vaccination and Non-Pharmaceutical Interventions for COVID-19 Prevention and Control J Zhao, Y Fu, P Han, L Yang
101 [GO] 2022―Jun―25 EPH167 Recursive Partitioning Analysis of COVID-19 Risk and Behavioral Measures in an Urban Setting O Mgbere, S Iloanusi, I Yunusa, NJR Iloanusi, S Gohil, EJ Essien
102 [GO] 2022―Jun―25 RWD57 Emergency and Inpatient COVID-19 Service Utilization and Its Stratification Based on Comorbid Conditions S Choudhary, A Gaur, I Kukreja, A Roy, A Chopra, A Gupta, et al. (+6)
103 [GO] 2022―Jun―25 RWD2 Variation in COVID-19 Treatment Cost due to Social Factors in the US - Estimation Using Integration of CDC/ATSDR’s Social Vulnerability Index (SVI) and Healthcare Claims Data A Roy, A Gaur, A Gupta, N Upadhyay, I Kukreja, A Chopra, et al. (+7)
104 [GO] 2022―Jun―25 EE386 Cost-of-Illness Analysis of Coronavirus Disease 2019 (COVID-19) Treatment in the Philippine General Hospital RM Castillo, V Chuabio, CI Panelo, C Jimeno
105 [GO] 2022―Jun―25 HSD5 Changes in COVID-19 Treatment Patterns over the Course of 2020 BA Turner, J Winer-Jones, A Maresca
106 [GO] 2022―Jun―25 EPH103 COVID-19 Vaccination Among Pregnant Women in the US: A Systematic Review S Rawal, RL Tackett, RH Stone, HN Young
107 [GO] 2022―Jun―25 HSD60 Children's COVID-19 Vaccination and Race - a Nationwide Survey of Children's Vaccination Status and Trust in the U.S. General Population E Heidari, CM Brown, R Morlock, K Blakomer, A Morlock
108 [GO] 2022―Jun―25 EPH60 Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US L Kallenbach, S Whipple, M Bonafede
109 [GO] 2022―Jun―25 HPR36 Using Best-Worst Scaling to Identify the Important Barriers to COVID-19 Vaccination in Black Belt Region: A Pilot Study H Yang, N Poudel, S Simpson, C Chou, S Ngorsuraches
110 [GO] 2022―Jun―25 EE71 Cost-Effectiveness of COVID-19 Vaccination in Colombia: A Micro-Simulation Modelling Analysis C Castañeda-Orjuela, N Alvis-Zakzuk, D Diaz-Jimenez, N Alvis-Guzman
111 [GO] 2022―Jun―25 P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study B. Jahn, G. Sroczynski, M. Bicher, C. Rippinger, N. Mühlberger, J. Santamaria, et al. (+3)
112 [GO] 2022―Jun―25 P10 Parental Vaccine Sentiment and Decision-Making Factors for Pediatric COVID-19 Vaccinations B. Wu, R. Almeida, N. Eslami, S. Garfield
113 [GO] 2022―Jun―25 HSD117 Sociodemographic Disparities in COVID-19 Vaccinations Still Exist 1 Year Following Vaccine Rollout J Rizk, FT Shaya
114 [GO] 2022―Jun―25 P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States M. Liu, A.C. Wong, J.T. McPheeters, R. Dixon, V. Madge, G. Basra, et al. (+2)
115 [GO] 2022―Jun―25 EPH75 COVID-19 Vaccine Breakthrough Infections in the United States, By Race M Liu, AC Wong, JT McPheeters, R Dixon, V Madge, G Basra, et al. (+2)
116 [GO] 2022―Jun―25 P15 Drivers of Health Disparities and Consequences for COVID-19 Vaccine Choices: Modelling Health Preference Heterogeneity Among Underserved Populations E. Van Den Broek-Altenburg, J. Benson, A. Atherly, S. Hess
117 [GO] 2022―Jun―25 EE188 COVID-19 Vaccine Hesitancy Among Early Adaptors in Jordan S Muflih
118 [GO] 2022―Jun―25 P14 Identification of COVID-19 Vaccine Hesitancy Predictors E. Saldarriaga
119 [GO] 2022―Jun―25 EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England S Aballea, P Karwala, I Zerda, M Toumi, M Pochopien, B Borissov, E Clay
120 [GO] 2022―Jun―25 EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5-17 Years: A Study of Reports from the VAERS Database Y Lee, A Gómez-Lumbreras, MS Tan, DC Malone, L Villa Zapata
121 [GO] 2022―Jun―25 SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population CY Shim, H Ghani, L Ahmad, H Sharif, MF Alikhan, S Bagol, et al. (+11)
122 [GO] 2022―Jun―25 EE7 Economic Evaluation of COVID-19 Vaccines: A Targeted Literature Review A Addae, L Ramjee, G Tremblay
123 [GO] 2022―Jun―25 EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS) AK Alahmari, Z Almalki, A Alshehri, AA Albassam, NJ Ahmed
124 [GO] 2022―Jun―25 EE238 Healthcare Costs of COVID-19 Versus Flu and Pneumonia - a Payer Perspective F Richards, B Patterson, J Ruppenkamp, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
125 [GO] 2022―Jun―25 RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine A Kolbin, SA Mishinova, GI Syraeva, YS Polushin
126 [GO] 2022―Jun―25 EPH55 Association Between Prior Bisphosphonate Use and COVID-19-Related Outcomes J Thompson, Y Wang, T Dreischulte, O Barreiro, R Gonzalez, P Hanč, et al. (+6)
127 [GO] 2022―Jun―25 EE456 Healthcare Resource Utilization Among Patients with Glycogen Storage Disease Type Ia (GSDIa) in the United States and the Impact of COVID-19: A Claims Database Analysis J Nedzesky, E Kruger, RN Gupta, NA Thomas, V Valayannopoulos
128 [GO] 2022―Jun―25 EE450 Treatments and Diagnostics for COVID-19: A Living Systematic Review of Economic Evaluations J Elvidge, A Summerfield, D Nicholls, D Dawoud
129 [GO] 2022―Jun―25 RWD44 Post-COVID Syndrome in Hospitalized Patients with COVID-19: A Prospective Cohort Study from a Health Care Plan in Brazil J Busch, J DOS Reis Neto
130 [GO] 2022―Jun―25 SA5 The Effectiveness and Safety of Remdesivir for COVID-19: A Quantitative Meta-Analysis AF Mohamed, P Duong, T Shah, M Zhang, RA Mekary
131 [GO] 2022―Jun―25 HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites P Rojas, C Epp, L Gozzo, D Geba, M Epstein, S Michel
132 [GO] 2022―Jun―25 HPR62 Economic Evaluations of Public Health Interventions on COVID-19: A Systematic Review A Rayanakorn, SL Leong, P Chaiprom, S Lee
133 [GO] 2022―Jun―25 EE334 Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with Coronavirus Disease 2019 F Richards, B Munoz, MW Fried, HL Morris, AR Mospan, JM Crawford, et al. (+4)
134 [GO] 2022―Jun―25 EPH121 A Descriptive Study on Hospital-Related Coronavirus Disease 2019 (HRCOVID-19) Among Chronic Kidney Disease Patients during the Pandemic at a Tertiary Center in the Philippines IMD Cruz, M Mendoza
135 [GO] 2022―Jun―25 EE483 The Economic Impact of Coronavirus Pandemic on Stroke Care: Direct and Indirect Costs Estimations in Chile D Paredes, R Lenz, K Hernández, L Paez
136 [GO] 2022―Jun―25 EPH140 SARS-COV-2 Breakthrough Infections Among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in the South Indian State of Kerala A Issac, J Kochuparambil
137 [GO] 2022―Jun―25 EPH137 Digital Health Solutions for Workers: Engagement with a Digital Tool for Management of SARS-COV-2 Exposure and Infection TB Gibson, L Schubel, V Assibey-Mensah, S Bloemers, C Pack, E Roemer, et al. (+4)
138 [GO] 2022―Jun―25 EPH120 Comparing the Effectiveness and Cost-Effectiveness of SARS-COV-2 Screening Strategies Using Rapid Antigen Tests in a Residential College Campus H Smolen, A Johnston, L Smolen, Y Yih
139 [GO] 2022―Jun―25 RWD72 SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS J Overcash, N Nguyen
140 [GO] 2022―Jun―25 EE43 Budget Impact Analysis of Favipiravir (AVIGAN®) for the Treatment of Patients with Confirmed Infection with SARS-COV2 in Mexico JÁ Paladio Hernández, BA Godina-Ortiz, A Lara-Terrazas
141 [GO] 2022―Jun―25 MT29 Optimal Strategies for Diabetic Foot Care in Times of Pandemic V Riquelme-Hidalgo, C Huiriqueo-Carrizo, K Reynaldos-Grandón
142 [GO] 2022―Jun―25 HSD16 Trends in Rheumatology Patient Care and Practice Operations Pre- and Post-COVID-19 Pandemic K Savill, A Klink, C Brown-Bickerstaff, Y Jeune-Smith, B Feinberg
143 [GO] 2022―Jun―25 PCR113 Depression Fallout from the Pandemic in a Sample of the Middle Eastern and North African (MENA) Community in Houston Texas, USA B Fatima, Z Majd, S Zeidat, F Atrooz, G Alrousan, S Abughosh, S Salim
144 [GO] 2022―Jun―25 HSD42 Trends in Non-COVID Healthcare Utilization during the Pandemic in Lebanon R Alameddine, Y Bassil, J Barhoun, K Asmar, C Maskineh
145 [GO] 2022―Jun―02 A Simulation-Based Cost-Effectiveness Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Prevention Strategies for Visitors of Healthcare Institutions Christina C. Bartenschlager, Selin Temizel, Alanna Ebigbo, Vivian Gruenherz, Petra Gastmeier, Helmut Messmann, et al. (+2)
146 [GO] 2022―May―06 “Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs Douglas C. Cheung, Karen E. Bremner, Teresa C.O. Tsui, Ruth Croxford, Lauren Lapointe-Shaw, Lisa Del Giudice, et al. (+11)
147 [GO] 2022―May―05 Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands Niek Mouter, Sander Boxebeld, Roselinde Kessels, Maarten van Wijhe, Ardine de Wit, Mattijs Lambooij, Job van Exel
148 [GO] 2022―Apr―28 Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials Stijntje W. Dijk, Eline M. Krijkamp, Natalia Kunst, Cary P. Gross, John B. Wong, M.G. Myriam Hunink
149 [GO] 2022―Apr―27 Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic Kandice A. Kapinos, Jordan R. Salley, Andrew Day
150 [GO] 2022―Apr―26 Americans’ Health Priorities During the COVID-19 Pandemic Joseph Cook, Melissa Pittaoulis, Kim Gilchrist, Justine Alderfer, Molly Sapia
151 [GO] 2022―Apr―12 Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic Rodrigo Murteira, Sónia Romano, Inês Teixeira, Carolina Bulhosa, Sérgio Sousa, Maria Inês Conceição, et al. (+3)
152 [GO] 2022―Apr―06 A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-health Impacts and Distributional Issues Meghan I. Podolsky, Isabel Present, Peter J. Neumann, David D. Kim
153 [GO] 2022―Apr―04 COVID-19 Health Economics: Looking Back and Scoping the Future Maarten J. Postma, Jagpreet Chhatwal
154 [GO] 2022―Mar―30 Update on a Model to Minimize Population Health Loss in Times of Scarce Surgical Capacity During the COVID-19 Crisis and Beyond Benjamin Gravesteijn, Eline Krijkamp, Anouk van Alphen, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, et al. (+8)
155 [GO] 2022―Mar―23 Electronic Patient Symptom Management Program to Support Patients Receiving Cancer Treatment at Home During the COVID-19 Pandemic Debra Wujcik, William N. Dudley, Matthew Dudley, Vibha Gupta, Jeannine Brant
156 [GO] 2022―Mar―19 Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing? Jagpreet Chhatwal, Anirban Basu
157 [GO] 2022―Feb―24 Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study Zhenyuan Chen, Xiaoxv Yin, Xiangping Tan, Jing Wang, Nan Jiang, Mengge Tian, et al. (+4)
158 [GO] 2022―Feb―20 A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales Rachid Rafia, Marrissa Martyn-St James, Sue Harnan, Andrew Metry, Jean Hamilton, Allan Wailoo
159 [GO] 2022―Feb―19 The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19 Melanie D. Whittington, Steven D. Pearson, David M. Rind, Jonathan D. Campbell
160 [GO] 2022―Feb―17 Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals Rena C. Moon, Harold Brown, Ning Rosenthal
161 [GO] 2022―Feb―16 Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations Jamie Elvidge, Ashley Summerfield, David Nicholls, Dalia Dawoud
162 [GO] 2022―Feb―05 Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World Rafael Dal-Ré, Magí Farré, M. Isabel Lucena
163 [GO] 2022―Feb―03 Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands Bram Wouterse, Frederique Ram, Pieter van Baal
164 [GO] 2022―Jan―20 P26 The Practice of Face Masking Among Young Adults in South India: An Online Cross-Sectional Survey During Second Wave of COVID-19 J Kochuparambil, A Issac
165 [GO] 2022―Jan―20 POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19 S Jhamb, S Khan, H Taneja, A Sachdev, D Mazumder, A Buikema
166 [GO] 2022―Jan―20 POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19 E Mozaffari, Z Zhang, M Thrun, RL Gottlieb, DR Kuritzkes, PE Sax, et al. (+5)
167 [GO] 2022―Jan―20 POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19. A Santos, ÉSD Gonçalves, AJF Oliveira, DB Lima, KVMDS Noronha, MV Andrade
168 [GO] 2022―Jan―20 POSA424 Challenges of COVID-19 Research: Results from a Systematic Literature Review on COVID-19 and Asthma or COPD S Grieve, P Daniele, AP Rabe, A Forsythe
169 [GO] 2022―Jan―20 POSB398 Kaplan-Meier Survival Curves Analysis of Hospitalized COVID-19 Beneficiaires of a Health Care Plan in Brazil JP Reis Neto, J Busch
170 [GO] 2022―Jan―20 POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States V Madge, N Bhardwaj, D Mazumder
171 [GO] 2022―Jan―20 P61 COVID-19 Concerns Experienced by Pregnant and Postpartum Women and Their Influence on Health-Related Quality-of-Life Swathi P Aytha, A Regan, E Grinshteyn, M Nosek, NY Gu
172 [GO] 2022―Jan―20 POSB266 NICE Published Oncology Recommendations: What Progress Has Been Made During the COVID-19 Era? E Samuels, M Tang
173 [GO] 2022―Jan―20 POSB425 Methodological Challenges to Coronavirus Disease (COVID-19) Evidence Generation to Inform Health Technology Assessment (HTA) K Rtveladze, J Gaultney, CJ Crossman-Barnes, S Kamra, D Wright
174 [GO] 2022―Jan―20 POSA383 Identification of Risk Factors Associated with COVID-19 Hospitalization A Chopra, A Arora, I Kukreja, A Gupta, V Verma, A Shukla
175 [GO] 2022―Jan―20 P6 Projecting COVID-19 Hospitalizations and Deaths Under Scenarios of Vaccination in Jefferson County, Kentucky N Patel
176 [GO] 2022―Jan―20 POSA394 Mortality Curves Analysis of COVID-19 Hospitalizations in Oncologic Patients of a Private Health Care Plan in Brazil JP Reis Neto, J Busch, S Stefani
177 [GO] 2022―Jan―20 POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico A Ponce-de-León, A Azamar-Alonso, F Silva-Sanchez, R Chirino-Sprung, V Dominguez-Esquivel, S Rajme-López
178 [GO] 2022―Jan―20 POSC172 The Long-Term Acceptability of COVID-19 Hygiene Measures, for the UK General Population G Roberts, B English, J Mumford, A Mumford
179 [GO] 2022―Jan―20 POSA21 An In-Hospital Study to Trace the Risk Factors Associated with Adverse Drug Reactions during the Second Wave of COVID-19 in a Secondary Care Hospital in India J Kochuparambil, A Issac
180 [GO] 2022―Jan―20 POSA420 Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database Z Icten, M Friedman, J Menzin
181 [GO] 2022―Jan―20 POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany JA Gossmann, C Meier, RA Greiner, J Otto, E Shlaen, A Batscheider
182 [GO] 2022―Jan―20 POSA393 Online Risk Calculator Using Machine Learning for Prediction of Survival After Hospital Discharge from COVID-19 Infection JP Reis Neto, J Busch, FN Barcellos Filho, EMJDM Farina, MCM Ferreira
183 [GO] 2022―Jan―20 POSC324 Clinical Pharmacist Intervention to Improve the Administration of Injectable Antiviral Agents By Nurses in the Treatment of COVID-19 Infection. A Nidha, J Kochuparambil, A Issac
184 [GO] 2022―Jan―20 POSA384 Identification of Complications Associated with COVID-19 Infection from Claims Data A Arora, A Chopra, I Kukreja, V Verma, A Shukla
185 [GO] 2022―Jan―20 POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project Esposti L Degli, A Ghigi, DD Ancona, M Andretta, A Barbieri, F Bartolini, et al. (+16)
186 [GO] 2022―Jan―20 POSA173 Onset of Stroke in Patients with Post-COVID-19 Syndrome Following Hospitalisation for Severe COVID-19 Infection: A Systematic Literature Review C Fleming, A Chakraborty, T Jaiswal, P Patel, S Nair
187 [GO] 2022―Jan―20 POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients R Burruss, V Arikian, K Oleru, T Traurig, M Stranz, J Lindhorst
188 [GO] 2022―Jan―20 POSC254 The Impact of COVID-19 on European HTA Decisions C Watson, JL Petrie, JA Toomey, C Shaw
189 [GO] 2022―Jan―20 P63 Impact of COVID-19 on Health-Related Quality-of-Life in the United States, Sweden and Norway: A Cross-Country Comparison Using a Panel Survey J Chen, CL Gong, X Jiao, NK Zawadzki, U Persson, JW Hay, NY Gu
190 [GO] 2022―Jan―20 P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective J Mycka, R Dellamano, W Lobb, N Dalal, L Dellamano, E Pereira
191 [GO] 2022―Jan―20 POSC185 Healthcare Utilisation, Health Inequality and the Impact of COVID-19 on Idiopathic Pulmonary Fibrosis (IPF) Care in England: A Retrospective Cohort Study J Bevan
192 [GO] 2022―Jan―20 POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season A Ngami, F Guelfucci, F Bianic, P Net
193 [GO] 2022―Jan―20 POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States A Ngami, T Christie, G Ménin, F Guelfucci, F Bianic, P Net
194 [GO] 2022―Jan―20 P28 Impact of COVID-19 on Mental Health in Young Adults in the United States T Intermill, CL Gong, NY Gu
195 [GO] 2022―Jan―20 POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey T Denee, K Pungor, Y Kambarov, R Nissinen, J Lee, K Ampeh, F Parmeggiani
196 [GO] 2022―Jan―20 POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital L Cazin, A Ngami, L Parrenne, F le Mercier, F Guelfucci, F Bianic, et al. (+2)
197 [GO] 2022―Jan―20 P25 Impact of COVID-19 on the Health-Related Quality-of-Life of Pregnant and Postpartum Persons A Regan, P Aytha Swathi, M Nosek, NY Gu
198 [GO] 2022―Jan―20 P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data S Pacis, U Maywald, T Wilke, M Ghiani
199 [GO] 2022―Jan―20 POSB278 Modernising the Clinical Trial: A Shift to Decentralised Trials Driven By Advances in Technology and Catalysed By the COVID-19 Pandemic N Cross, N Kipentzoglou, J Whitehouse, A Satherley
200 [GO] 2022―Jan―20 P27 Vaccination Coverage Trends for Hepatitis B in Infants from the Brazilian and Colombian Expanded Immunization Program: A Real-World Analysis of COVID-19 Pandemic Impact P Lima, A Abreu, F Hernández, J Martins, B Kano, D Kashiura, G Julian
201 [GO] 2022―Jan―20 P22 COVID-19 Pandemic Impacts Volume of Evaluation & Management (E&M) Telehealth Visits within Community Oncology Practices M Karhade, N Mohammad, N Robert, N Wu, B Heller, S Alwardt, et al. (+3)
202 [GO] 2022―Jan―20 POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes S Pacis, U Maywald, T Wilke, M Ghiani
203 [GO] 2022―Jan―20 POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries ML Davis-Ajami, ZK Lu, J Wu
204 [GO] 2022―Jan―20 POSC218 Study of Antibiotic Consumption Trends in Public Pharmacies during the COVID-19 Pandemic in Ukraine O Zaliska, O Semenov, Z Zabolotnya, N Maksymovych, O Brezden, B Zaliskyy, I Mudrak
205 [GO] 2022―Jan―20 POSA233 The Indirect Health Economic Consequences of the COVID-19 Pandemic on English Hospitals: A Scoping Review D Jones, L Barham
206 [GO] 2022―Jan―20 POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies P Net, J de Renteria, F Bianic
207 [GO] 2022―Jan―20 P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany J Krieger, F Hardtstock, T Wilke, U Maywald
208 [GO] 2022―Jan―20 POSA363 Lasting Impacts of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B Halioua, A Astruc, M Gourdon, A Bombezin--Domino, L Radoszycki
209 [GO] 2022―Jan―20 POSA279 The Impact of the COVID-19 Pandemic on the MHRA’s Early Access to Medicines Scheme P Ruane, R Brown, LE Francis, L Sam
210 [GO] 2022―Jan―20 P62 The Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Melanoma - Findings from a UK Melanoma Registry M Heinrich, D Mulgina, A Kudlac, C Ouyang, M Larkin, A Ofori
211 [GO] 2022―Jan―20 POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case E Viayna, FJ Candel, D Callejo-Velasco, R Ramos, J San-Roman, P Barreiro, et al. (+5)
212 [GO] 2022―Jan―20 POSA247 Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies during COVID-19 Pandemic: A Single-Arm, Before-and-After Study R Murteira, S Romano, I Teixeira, H Galante, S Sousa, A Teixeira Rodrigues
213 [GO] 2022―Jan―20 POSB248 Medication Management Practices for Non-Communicable Diseases during the Second Wave of the COVID-19 Pandemic: A Snapshot of the European Situation P Kardas, JFM van Boven, B Wettermark, E Menditto, H Pinnock, I Tsiligianni, T Agh
214 [GO] 2022―Jan―20 POSB396 Identification of Risk Factors Associated with ICU Admission in COVID-19 Patients I Kukreja, A Chopra, A Arora, V Verma, A Shukla
215 [GO] 2022―Jan―20 POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients E Mozaffari, S Liang, HM Stewart, M Thrun, P Hodgkins, R Haubrich
216 [GO] 2022―Jan―20 POSC44 Extra Regional COVID-19 Patients Transfers: A Retrospective Analysis of Distance, Time and Cost for Train, Helicopter and Fixed-Wing Ambulances A Girault, P Chauvin, P Cucharero Atienza, N Sirven, O Grimaud
217 [GO] 2022―Jan―20 POSC1 The Influence of Diabetic History in the Prognosis of Hospitalized COVID-19 Patients: A Prospective Observational Study A Issac, J Kochuparambil
218 [GO] 2022―Jan―20 POSB103 COVID-19 Positive Patients Hospital Management in the Italian Setting: The Economic Impact LB Ferrario, F Schettini, E Porazzi, M Dalla Bona, MB Pagani, T Dezi, et al. (+8)
220 [GO] 2022―Jan―20 POSA286 Early Experience with Health Technology Assessments for COVID-19 Treatments X Sitavu-Radu, T Tulika, R Rajani, S Vasileva
221 [GO] 2022―Jan―20 POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated? A Vives, L Armand, L Radoszycki, O Wilczynski
222 [GO] 2022―Jan―20 POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study B Jahn, G Sroczynski, M Bicher, C Rippinger, N Mühlberger, J Santamaria, et al. (+3)
223 [GO] 2022―Jan―20 POSC117 A Public Health and Budget Impact Analysis (BIA) of COVID-19 Vaccination in Austria M Traunfellner, F Meyer, E Walter
224 [GO] 2022―Jan―20 POSC407 Monitoring of Reported COVID-19 Vaccination Rates in Community Oncology Settings R Harrell, A Kwon, M Karhade, N Robert, N Wu, B Heller, et al. (+3)
225 [GO] 2022―Jan―20 P20 Evaluating Preferences and the Effect of Altruism on COVID-19 Vaccine Decisions: A Discrete Choice Experiment M Kelley, EF Drabo, CL Gong
226 [GO] 2022―Jan―20 POSB193 COVID-19 Vaccine Development Pipeline: 2021 R Ahlawat, R Singhal, A Rajput, R Goyal
227 [GO] 2022―Jan―20 POSB222 Can Gene Therapy Prices Remain the Same? What We Have Learned from the COVID-19 Vaccines K Sigurðardóttir, O Sola-Morales
228 [GO] 2022―Jan―20 POSA225 Comparing the US Drug Development, Pricing, Access, and Reimbursement Strategies for COVID-19 Vaccines as a Potential Model for Novel Oncology Therapies Y Lee, K Lee, H Park, M Neese, ZM Khan
229 [GO] 2022―Jan―20 POSB328 Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living with HIV/AIDS in the Era of COVID-19: A Qualitative Experience from a Low Middle-Income Country A Ahmed, J Dujaili, A Awaisu, FK Hashmi
230 [GO] 2022―Jan―20 POSC102 High-Flow Nasal Cannula in Patients with COVID-19: Is a Cost-Effective Alternative? JM Alves Junior, D Villagelin, FE Prota, A Chrispim, C Silva, E Yamanaka, et al. (+7)
231 [GO] 2022―Jan―20 POSC413 A Systematic Review of Real-World Clinical Practice Data in COVID-19: Non-Interventional Studies S Mishinova, J Gomon, A Kolbin, VV Strizheletsky, I Ivanov
232 [GO] 2022―Jan―20 P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective M Schöttler, S Van der Schans, M Postma, C Boersma
233 [GO] 2022―Jan―20 P23 Change in Healthcare Utilisation and Inpatient Mortality in Patients Hospitalised with Heart Failure during the Coronavirus Pandemic in England: A Retrospective Cross-Sectional Study Utilising HES D Jones, L Barham
234 [GO] 2022―Jan―20 POSB178 Geographical Inequalities in Coronavirus (SARS-COV-2) Mortality in Europe D Elmer, D Endrei, T Csákvári, N Németh, L Horváth, N Danku, et al. (+2)
235 [GO] 2022―Jan―20 POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2 AF Cobre, A Junkert, MM Fachi, B Böger, M Surek, A Wiens, et al. (+2)
236 [GO] 2022―Jan―20 POSA210 Decentralized Study Methods: A Summary of the Regulatory Landscape in the SARS-COV-2 Era and Beyond A Bevan, M Baltezegar
237 [GO] 2022―Jan―20 POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection B Iacolare, V Perrone, D Sangiorgi, A Ghigi, E Giacomini, C Nappi, et al. (+16)
238 [GO] 2022―Jan―20 P24 Telehealth Access and Use by the U.S. Medicare Population during the Pandemic T Swenson
239 [GO] 2022―Jan―20 POSA234 The Value of a Large Care Network in Delivering Continuity of Care to Clinically Extremely Vulnerable People During a Global Pandemic: A UK Case Study S Boeger, E Busink, G Dewsnap, K Basnayake, M Beaumont
240 [GO] 2021―Dec―11 The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe Luz María Peña-Longobardo, Juan Oliva-Moreno, Beatriz Rodríguez-Sánchez
241 [GO] 2021―Dec―08 Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries Jichao Sun, Yefeng Zheng, Wenhua Liang, Zifeng Yang, Zhiqi Zeng, Tiegang Li, et al. (+4)
242 [GO] 2021―Oct―16 Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review Oscar Lau, Nirma Khatri Vadlamudi
243 [GO] 2021―Sep―30 Cost-Effectiveness of Coronavirus Disease 2019 Policy Measures: A Systematic Review Sophie Vandepitte, Tijs Alleman, Ingmar Nopens, Jan Baetens, Samuel Coenen, Delphine De Smedt
244 [GO] 2021―Aug―05 Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories J. Jaime Caro, Jörgen Möller, Vatshalan Santhirapala, Harpreet Gill, Jessica Johnston, Kariem El-Boghdadly, et al. (+3)
245 [GO] 2021―Aug―05 Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios William F. Vásquez, Jennifer M. Trudeau
246 [GO] 2021―Jul―31 Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic Brittany R. Lapin, Wai Hong Wilson Tang, Ryan Honomichl, Olivia Hogue, Irene L. Katzan
247 [GO] 2021―Jun―04 PNS21 Protection Motivation Theory in Predicting Intention to Engage in Protective Behaviors Against NOVEL Coronavirus Diseases (COVID-19) G. Adunlin, H. Galadima, C. Cropp, J.C. Cagle
248 [GO] 2021―Jun―04 PMU1 Evolving Access Under COVID-19 J. Cook
249 [GO] 2021―Jun―04 PNS36 VALUE Based Procurement: A Tool to Make Better Purchasing Decisions after COVID-19 G. Prada, C. Brabata, D. Guarin, R. Iunes, R. Lenz, V. Zamora Mesia
250 [GO] 2021―Jun―04 PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19 F. Kamgar, R. Hughes, S. Lucherini
251 [GO] 2021―Jun―04 PNS69 Burnout Syndrome Prevention In Nursing At Pandemic (Covid-19): A Literature Review F. Caballol-Avendaño, A. Flores-Hoyos, J. Guerra-Cruz, V. Merillu-González, F. Morales-Vizcarra, K. Reynaldos-Grandón
252 [GO] 2021―Jun―04 PCV40 Cardiovascular Outcomes Associated with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis H. Alkofide, R. Almesned, L. Alnoghaimshi, Z. Alkherb, G. Alhindi, G. Korayem
253 [GO] 2021―Jun―04 PIN52 Effectiveness in Reducing the Risk of Death and Severity of a SET of Measures Against COVID-19 : The Case of an Insured Population in the Colombian Caribbean F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
254 [GO] 2021―Jun―04 IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample V. Divino
255 [GO] 2021―Jun―04 PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24 Sands-Lincoln. M, H. Huang, G.P. Jackson, S. Wang
256 [GO] 2021―Jun―04 PNS13 Comparative Network Efficiency Analysis of Brazil Response to COVID-19 at State Level T. Nepomuceno, W.M. Silva, S.D.F. Gomes, T.F.O. Rodriguez
257 [GO] 2021―Jun―04 PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL J. Guo, J. Yang, J. Muzumdar, T. Park
258 [GO] 2021―Jun―04 PIN40 Risk Factors for Severe Outcomes in COVID-19 Confirmed or Suspected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, S. Ramachandran, E. Pittman, K. Bhattacharya, J.P. Bentley, B. Banahan, et al. (+2)
259 [GO] 2021―Jun―04 PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome D. Araja, U. Berkis, A. Lunga, M. Murovska
260 [GO] 2021―Jun―04 PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods D. Sheinson, Y. Meng, D. Elsea
261 [GO] 2021―Jun―04 PIN58 The U.S. International Trade of Medical Products in the COVID-19 Era S.M. Preciado, K. Lotfi, E. Seoane-Vazquez, R. Rodriguez-Monguio, P. Brancazio
262 [GO] 2021―Jun―04 PRS24 Utilizing Blue Cross Blue Shield of Louisiana (BCBSLA) Risk of Hospitalization (ROH) AI Predictive Model to Help Louisiana Identify Patients at High Risk for a COVID-19 Hospital Admission J. Holloway, M. Cong, J. Ouyang, B. Vicidomina, S. Nigam
263 [GO] 2021―Jun―04 PCN238 COVID-19 Impact on Breast and Prostate Cancer Screening, Diagnosis, and Surgery: A Real-World Study from the Brazilian and Colombian Public Healthcare System Perspectives P.V.P. Lima, L. van der Werf, R. Ferreira, D. Kashiura, L. Ono, G. Julian, et al. (+2)
264 [GO] 2021―Jun―04 PNS14 Direct Medical Costs Related to COVID-19 in Colombia N. Alvis-Zakzuk, A. Florez-Tanus, D. Diaz-Jimenez, P. Chaparro-Narvaez, C. Castañeda-Orjuela, F. De La Hoz, et al. (+2)
265 [GO] 2021―Jun―04 PRS21 Quantifying the years of life lost due to COVID-19 in Colombia: preliminary estimates N. Alvis-Zakzuk, N. Alvis-Guzman, D. Diaz-Jimenez, C. Dueñas Castell, J. Rojas-Suarez, J.C. Fernandez Mercado, et al. (+3)
266 [GO] 2021―Jun―04 PIN32 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in Europe and Asia E. Achter, Y. Shen, R. Goldgrub, R. Kendall, D. Shah
267 [GO] 2021―Jun―04 PDB48 Increased Mortality of COVID-19 in Patients with Diabetes: A Retrospective Cohort Study in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
268 [GO] 2021―Jun―04 PIN41 The Public Health Implications of Google Trends and News Coverage for COVID-19 in the Early Epidemic Stage: A Multinational Study in Eight Countries F. Huang, G. Feng, T. Liu, Q. Chen, T. Jian, Q. Zhong, et al. (+4)
269 [GO] 2021―Jun―04 PIN22 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in the USA Y. Shen, R. Goldgrub, E. Achter, R. Kendall, D. Shah
270 [GO] 2021―Jun―04 PIN42 Molecular Testing Dynamics Is Reactive to COVID-19 Incidence: Observations from the Colombian Experience A. Lozano, J. Zakzuk, F. Salcedo Mejía, L. Moyano, N. Alvis-Zakzuk, N.R. Alvis-Zakzuk, N. Alvis-Guzman
271 [GO] 2021―Jun―04 IN4 Non-Health Considerations in Economic Evaluations of COVID-19 Interventions: A Systemic Review M. Podolsky, D. Kim, P.J. Neumann
272 [GO] 2021―Jun―04 PIN44 COVID-19 Knowledge, and Mental Health IMPACT Assessment in Haiti Y. Gousse, T. Jean
273 [GO] 2021―Jun―04 PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study P.B. Samaksha, R.K. Puvvada
274 [GO] 2021―Jun―04 PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis E. Guidotti, S. Manetti, M. Vainieri, F. Attanasio, N. Orsini
275 [GO] 2021―Jun―04 PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria F. Fatoye, T. Gebrye, O.O. Arije, C. Fatoye, O. Onigbinde, C. Mbada
276 [GO] 2021―Jun―04 PIN77 Engagement in Preventive Behaviors Following Exposure to COVID-19 News on Social Media T. Park, I. Ju, J. Ohs, A. Hinsley, J. Muzumdar
277 [GO] 2021―Jun―04 PMU48 The IMPACT of COVID-19 on European Health Technology Assessments P. Wagner, J. Zlateva, A. van Engen, S. Plantör
278 [GO] 2021―Jun―04 PMU45 The Impact of COVID-19 on Patient Management across the EU and US J. Piercy, E.A. Holdsworth, J. Austin, M.J. Hughes, K. Khela, G. Taylor-Stokes, J. Hall
279 [GO] 2021―Jun―04 PNS67 Gaining Trust in the Use of Virtual Meetings for Health Technology Assessment during the COVID-19 Pandemic J. Dickson, M. Pierre, L. Lockhart, J. McCormack
280 [GO] 2021―Jun―04 PNS56 Survey of the Awareness of Pharmacists about Quarantine Measures during the COVID-19 Pandemic O. Semenov, O. Zaliska, N. Maksymovych, V. Huz, Z. Zabolotnya
281 [GO] 2021―Jun―04 PMU58 Americans' Health Priorities during the COVID-19 Pandemic J. Cook, M. Pittaoulis, K. Gilchrist, J. Alderfer, M. Sapia
282 [GO] 2021―Jun―04 PMH24 Demographic and Clinical Factors Associated with Post Traumatic Stress Disorder (PTSD) during the COVID-19 Pandemic B.L. Rosario, H. Huang, G.P. Jackson, B. Kolt, S. Wang
283 [GO] 2021―Jun―04 PIN8 Application of Innovative Pricing in Response to the COVID-19 Pandemic C. Akunne, B. Connelly, S. Bathija
284 [GO] 2021―Jun―04 PDB28 Innovative Application of a Mobile APP for Gestational Diabetes Health Education in the Era of the COVID-19 Pandemic and BIG DATA G. Feng, F. Huang, Q. Chen, Q. Zhong, T. Liu, D. Hao, et al. (+3)
285 [GO] 2021―Jun―04 PRS32 Management Of The Covid-19 Pandemic Around Public Health: Ethical Perspectives C. Alcayaga, V. Loor-Sánchez, N. Oyarce-Hormazábal, M.P. Riveros-Riveros, K. Reynaldos-Grandón
286 [GO] 2021―Jun―04 PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
287 [GO] 2021―Jun―04 PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil? R. Arcaro, C.R. Pereira da Veiga, C. Da Veiga
288 [GO] 2021―Jun―04 PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia J. Pesa, J.N. Liberman, M. Petrillo, C. Ruetsch
289 [GO] 2021―Jun―04 PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization P. Arora, J. Ha, D. Mehta
290 [GO] 2021―Jun―04 PUK19 DATA Quality Considerations for Determining the IMPACT of the COVID-19 Pandemic on Outpatient Visits and Procedures in the United States P. Brendel, R. Jain, A. Lien, D. Lee, J.B. Shelton, R. Fang, et al. (+4)
291 [GO] 2021―Jun―04 PMU63 Post-Lockdown Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in the United States B. Halioua, J. Zetlaoui, A. Astruc, M. Harrizi, A. Bombezin--Domino, L. Radoszycki
292 [GO] 2021―Jun―04 PIN20 Predicting the IMPACT of Vaccination Strategies in the COVID-19 Pandemic Using a Susceptible-Exposed-Infectious-Removed (SEIR) MODEL W. Song, Y. Yi
293 [GO] 2021―Jun―04 PCN120 Clinical and Economic Consequences of Delayed Care Due to the COVID-19 Pandemic- Focus on Mammograms and Breast Cancer K. Infante, N. Eslami, S. Garfield
294 [GO] 2021―Jun―04 PIN47 COVID-19 Patient Severities in Japanese EMR M. Okada, S. Wada, M. Isshiki, S. Utsunomiya, T. Akiyama, K. Hamada, S. Demiya
295 [GO] 2021―Jun―04 PIN74 Health-Related Quality of Life (HRQoL) in COVID-19 Patients - a Systematic Literature Review N. Goli, N. Kayam, N. Kumar, D. Shah
296 [GO] 2021―Jun―04 PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases S.W. Kim, T. Ishii, S. Takeno, Y. Kado, Y. Tamai, T. Akiyama, et al. (+2)
297 [GO] 2021―Jun―04 PIN64 Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System V. Kumar, L. Rasouliyan, S. Long, M.B. Rao
298 [GO] 2021―Jun―04 IN1 Treatment Journey of COVID-19 Patients in Hospital Settings R. Moon, N. Rosenthal, H. Brown
299 [GO] 2021―Jun―04 IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States F. Sun, S. Jeyakumar, N. Smith
300 [GO] 2021―Jun―04 ML2 Supervised Machine Learning Predicts Mortality in COVID-19 Patients Using Electronic Health Records X. Marinaro, Z. Meng, X. Zhang, K. Lodaya, D.K. Hayashida, S. Munson, F. D'Souza
301 [GO] 2021―Jun―04 PIN1 Polypharmacy Among COVID-19 Patients: A Prisma-Based Systematic Review of Available Literature S. Iloanusi, O. Mgbere, E.J. Essien
302 [GO] 2021―Jun―04 PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System R. Ivos, I. Ribeiro-Vaz, J. Polónia, A. Silva
303 [GO] 2021―Jun―04 PRS30 COVID-19 RAPID Antigen Test False Positives and False Negatives Reported to the FDA Manufacturer and User Facility Device Experience Database M. Zettler, A. Gajra, B. Feinberg
304 [GO] 2021―Jun―04 PIH22 Efficacy Of Telephone-Based Educational Intervention On Knowledge Transfer Of COVID-19 Related Health Topics To Elderly Citizens In Hong Kong: A Pilot Study M.Y. Fung, Y.H. Lee, Y.T.A. Lee, M.L. Wong, J.T.S. Li, V. Lee
305 [GO] 2021―Jun―04 PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey N.J.R. Iloanusi, S. Iloanusi, O. Mgbere, A.I. Ajayi, E.J. Essien
306 [GO] 2021―Jun―04 PIN83 The COVID-19 Research Database: Building One of the Largest PRO Bono Real-World DATA Repositories A. Talwai, V. Wing, Y. Itzkovich, A. Galaznik, A. Chatterjee, R. Jain, J. LaBonte
307 [GO] 2021―Jun―04 PNS105 Patient Preferences and Feedback Regarding Daily Reporting of COVID-19 Symptoms Using Personal Smartphones for the Obvio-19 Study S. Dallabrida, H. Linke, P. Shah, M. Culbreth-Notaro
308 [GO] 2021―Jun―04 PIN54 Analysis of COVID-19 Treatment Drugs Availability in Ukraine O. Blavatska, I. Blavatskyi
309 [GO] 2021―Jun―04 PIN63 Choosing the Right COVID-19 Vaccine: A Multiple Stakeholder Multicriteria Decision Analysis For the Assessment of Available Vaccines in Latin America M.A. Espinoza, J. Guzman, J. Soto, G. Hernandez, D. Guarin, V. Boers Trilles, M. Martin De Bustamante
310 [GO] 2021―Jun―04 PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review O. Lau, N. Vadlamudi
311 [GO] 2021―Jun―04 PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults K. Rajagopalan, B. Mahadik
312 [GO] 2021―Jun―04 PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World C. Hildreth, K. Infante, N. Eslami, S. Garfield
313 [GO] 2021―Jun―04 PIN50 Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods S. Emerson, K. Johnston, A. Howarth, J. Schneider, M. Friesen, S. Szabo
314 [GO] 2021―Jun―04 PIN51 Role of Asymptomatic Carriers in the Transmission of COVID-19: A Review U. Abubakar, M. Hammad
315 [GO] 2021―Jun―04 PND48 Real World Data and COVID-19: Healthcare Impact in Emergency Care, Stroke Emergency Care and Stroke-Related Deaths in Chile L. Paez, R. Lenz, D. Paredes
316 [GO] 2021―Jun―04 PIN59 COVID-19: The Real-World Hospitalized Patient Experience L. Rasouliyan, V. Kumar, S. Long, M.B. Rao
317 [GO] 2021―Jun―04 PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19? K. Hernández, D. Paredes, R. Lenz
318 [GO] 2021―Jun―04 PMH18 Emotional Well-Being Among Pharmacy Students during the COVID Pandemic M. Zakeri, La Cruz A De, D. Wallace, S.D. Sadeghi, S.S. Sansgiry
319 [GO] 2021―Jun―04 MT1 Telehealth Utilization and Multiple Sclerosis Imaging Utilization in Four MS Centers during the COVID Pandemic: Real-world evidence from the MS-CQI improvement research collaborative. A. Chen, M. Molaei, A. Vaeth, K. Walsh, B. Oliver
320 [GO] 2021―Apr―19 Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic Jagpreet Chhatwal, Maarten J. Postma
321 [GO] 2021―Mar―11 Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands Niek Mouter, Marion Collewet, G. Ardine de Wit, Adrienne Rotteveel, Mattijs S. Lambooij, Roselinde Kessels
322 [GO] 2021―Mar―10 Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs Charles F. Manski, Aleksey Tetenov
323 [GO] 2021―Mar―09 Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States Anirban Basu, Varun J. Gandhay
324 [GO] 2021―Mar―06 Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study Benjamin Gravesteijn, Eline Krijkamp, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, Sophie Bruinsma, et al. (+7)
325 [GO] 2021―Feb―21 Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies Jidi Zhao, Huajie Jin, Xun Li, Jianguo Jia, Chao Zhang, Huijuan Zhao, et al. (+9)
326 [GO] 2021―Feb―21 How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Adrian Towse, Kalipso Chalkidou, Isobel Firth, Hannah Kettler, Rachel Silverman
327 [GO] 2020―Dec―11 PIN166 Health-Related Quality of Life (HRQOL) Outcomes and Potential Interventions in Patients Diagnosed with COVID-19. M. Sehgal, V. Pandey
328 [GO] 2020―Dec―11 PMD34 RAPID Medtech Innovation Briefings for COVID-19 R. Owens, Y. Wang, K. Carter
329 [GO] 2020―Dec―11 PIN170 The NOVEL Coronavirus Disease (COVID-19): Impacts on TESTS and Hospitalizations Performance in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
330 [GO] 2020―Dec―11 PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System S. Boeger, J. Petrovic, E. Busink, C. Apel, F. Kircelli, R. Pohlmeier
331 [GO] 2020―Dec―11 PIN167 Patient-Reported Outcomes to Capture the Signs, Symptoms and Impacts of COVID-19 and the IMPACT of the Pandemic on People with and without Infection M. Reaney, K. Heuer, J. Turnbull, J. Paty
332 [GO] 2020―Dec―11 CO2 WHEN Could a Second Wave of COVID-19 Appear in Germany and How Strong Will IT be? a Simulation Analysis S. Walzer
333 [GO] 2020―Dec―11 PIN120 The IMPACT of LONG-TERM Exposure to PM2.5, PM10 and NO2 Air Pollutants on the Age-Adjusted Mortality RATE of COVID-19 Based on the Example of Poland. A. Musiałek, A. Nosowicz
334 [GO] 2020―Dec―11 PIN122 Racial Disparity in COVID-19 Burden at the US Epicenter M. Bhattacharyya, R. Bhattacharyya, L.E. Miller, A.L. Miller, C. Stewart, S. Rojanasarot
335 [GO] 2020―Dec―11 PIN78 County-level differences in COVID-19 cases and fatalities in Germany A. Batscheider, J.A. Gossmann, R.A. Greiner, E. Shlaen, B. Antoni, D. Böckmann, et al. (+2)
336 [GO] 2020―Dec―11 PIN81 Within Country Regional Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in Hungary I. Boncz, A. Sebestyén, J. Betlehem, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
337 [GO] 2020―Dec―11 PIN112 Geographical Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in the European Union I. Boncz, E. Dora, A. Sebestyén, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
338 [GO] 2020―Dec―11 CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints Z. Kocaata, I. Simankova, T. Wilke
339 [GO] 2020―Dec―11 PNS245 Do Patient Preferences Change in a Pandemic? Exploring Italian Patient Reported Experience DATA during the COVID-19 Crisis K. Jamieson Gilmore, S. De Rosis, S. Nuti
340 [GO] 2020―Dec―11 PIN124 Analysis of Race and Ethnicity of COVID-19 Deaths in the United States C. Xavier, R. Rasu
341 [GO] 2020―Dec―11 PIN114 Estimation of Quality-Adjusted Life YEARS (QALY) Losses Associated with COVID-19 Deaths in Ukraine V. Serediuk, O. Piniazhko, O. Topachevskyi, T. Dumenko, L. Kovtun
342 [GO] 2020―Dec―11 PIN117 Identification of Patients with COVID-19 Infection Prior to the New COVID-19 Diagnostic Code - a Premier Database Analysis. C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+4)
343 [GO] 2020―Dec―11 PRS41 Understanding the Clinical Burden of ACUTE Respiratory Distress Syndrome (ARDS) in a COVID-19 Era - a Targeted Search and Epidemiological MODEL D. Tomaras, S. Harricharan, G. Tremblay, F. Anna
344 [GO] 2020―Dec―11 PCN224 An Italian Experience: How the COVID-19 Era HAS Modified the Radiological Activity in a Cancer Hospital A. Rossi, A. Prochowski Iamurri, C. Cerchione, N. Gentili, V. Danesi, M. Altini, et al. (+2)
345 [GO] 2020―Dec―11 PNS10 Research in the COVID-19 Era: Accelerating the Shift in the Research Paradigm from Traditional Towards Digital/Virtual Solutions D. Stein, M. Baltezegar
346 [GO] 2020―Dec―11 PIN178 Impact of Selected Comorbidities on Healthcare Resource Utilization Among Hospitalized Patients with COVID-19 in a US Population Z. Icten, I. Livingstone, J. Menzin
347 [GO] 2020―Dec―11 PMH16 Productivity, Depression, and Measures to Reduce Social IMPACT: The Economic IMPACT of COVID-19 in Brazil R. Andrade, D. Sansone, D. Farah, R. Garcia, G. Tannus, M. Fonseca
348 [GO] 2020―Dec―11 PIN90 Characteristics of Patients Died Due to Coronavirus Disease 2019 (COVID-19) in Hungary I. Boncz, J. Betlehem, E. Dora, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
349 [GO] 2020―Dec―11 PIN65 Socio-Economic Burden of COVID-19 in Russian Federation A. Kolbin, J. Gomon, Y. Balykina, D. Belousov, I. Ivanov
350 [GO] 2020―Dec―11 PIN75 Characteristics of Patients Diagnosed with COVID-19 in the US: A Descriptive Claims-Based Study from a National Perspective V. Divino, Y. Wang, C. Beggs, M. DeKoven
351 [GO] 2020―Dec―11 PIN87 Comparing Methodologies to Predict Incidence of COVID-19 in US Counties P. Coplan, S. Shah, A. Bhardwaj, A. Gurubaran, H. Dwarakanathan, G. Cafri, et al. (+5)
352 [GO] 2020―Dec―11 IN3 Impact of Government Measures on COVID-19 Incidence of Reported New Cases: An Analysis of 9 Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
353 [GO] 2020―Dec―11 PIN17 Healthcare Resource Utilization and Cost in Patients with Inpatient Mortality Due to COVID-19 Infection C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+5)
354 [GO] 2020―Dec―11 PIN82 The Influence of Social Distancing on COVID-19 Infections in the U.S. P. Coplan, G. Cafri, R. Khanna, A.S. Chitnis, B. Nandi, H. Dwarakanathan, et al. (+5)
355 [GO] 2020―Dec―11 PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States J. Chhatwal, O. Dalgic, P. Mueller, M. Adee, Y. Xiao, M.A. Ladd, et al. (+2)
356 [GO] 2020―Dec―11 PMH29 To Assess the Psychological IMPACT of COVID-19 Lockdown Among Healthy Individuals in India. S. P.B., K. Undela, R.K. Puvvada, B. Gupta, K. Manohar Rao, S. Palaksha
357 [GO] 2020―Dec―11 PIN139 The Cost-Effectiveness of COVID-19 Lockdowns in the United States R. Becker
358 [GO] 2020―Dec―11 PIN85 The Application of Global Influenza Pandemic Mortality Progression and Vaccine Production Strategies As Analogues for COVID-19 Management and Understanding. C. Fidler
359 [GO] 2020―Dec―11 CO3 Effectiveness of Government Measures to Reduce COVID-19 Mortality across 5 Different Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
360 [GO] 2020―Dec―11 PRS56 Cost-Effectiveness of Social Distancing to Reduce COVID-19 Mortality in the United States B. Bloudek, K. Migliaccio-Walle, P.J. Barrett, V. Nguyen, L. Bloudek
361 [GO] 2020―Dec―11 PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities M. Thomas, P. Craddy, G. Foxon
362 [GO] 2020―Dec―11 PCN3 IMPACT of COVID-19 on Immunotherapy Utilization in Metastatic NON-SMALL Cell LUNG Cancer P. Chopra, Y. Zhai, M. Myers
363 [GO] 2020―Dec―11 PCN293 Understanding Real-World Experiences and Impacts of COVID-19 on Patients with Breast Cancer: A Social MEDIA Listening Analysis S. Halhol, M. Raluy-Callado, M. Oguz, A. Booth
364 [GO] 2020―Dec―11 PNS263 Pandemics and Access to Care: Use of Real-World DATA to Examine the IMPACT of COVID-19 on Pharmacy Visits in JAPAN M. LoPresti, T. Seo, N. Sato
365 [GO] 2020―Dec―11 PMU84 IMPACT of COVID-19 on Physician Engagement and Life Science Companies' Digital and Operational Strategy N. Eslami, B. Harris, V. Parris, P. Sharan, S. Butler, K. Infante, et al. (+3)
366 [GO] 2020―Dec―11 PMD42 The IMPACT of COVID-19 on Telemedicine in Ophthalmology: A Literature Review D. O'Boyle, F. Carones, K. Darcy, B.S. Malyugin, R. Rejdak, L. Moccaldi, F. Vidal Aroca
367 [GO] 2020―Dec―11 PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies C. Teale, A. Roldan-Gomendio, S. Heinz, C. Sayadian, N. Jimenez
368 [GO] 2020―Dec―11 PIN123 How Much Will the COVID-19 Outbreak Have Cost the German Health Care System in the First Months Since the Outbreak? S. Walzer, L. Vollmer, S. Krenberger
369 [GO] 2020―Dec―11 PSU20 Attitude of Hungarian Adults Towards Emergency Plans before COVID-19 Outbreak in Hungary A. Kovács, A. Oláh, A. Pakai, E. Inhoff, G. Far, K. Wirthné-Gyergyák, et al. (+2)
370 [GO] 2020―Dec―11 PIN173 Studying Fake News on Twitter during the COVID-19 Pandemia in France A. Gedik, P. Foulquié, S. Renner, A. Mebarki, N. Texier, S. Schück
371 [GO] 2020―Dec―11 PIN66 A Scoping Review of the Literature on the Multifactorial Health-Economics Burden Caused By the COVID-19 Pandemic L. Chillotti, N. Largeron, G. Olivera
372 [GO] 2020―Dec―11 PIN126 Russian Mandatory Medical Insurance System Response to COVID-19 Pandemic M. Avxentyeva, V. Omelianovskiy, I. Zhelezniakova
373 [GO] 2020―Dec―11 PIN133 Medical Human Resource NEEDS of Chinese Health Professionals during the COVID-19 Pandemic. W. Hao, Z. Zhuang, W.K. Ming
374 [GO] 2020―Dec―11 PIN152 How Much Does a Life Cost? Lessons from the COVID-19 Pandemic A. Estévez-Carrillo, M. Cerezales, C. Crespo
375 [GO] 2020―Dec―11 PMD33 Estimating Societal Costs Associated with Vision Loss and Delayed Cataract Surgery: The Potential IMPACT of the COVID-19 Pandemic. D. O'Boyle, R. Busutil, L. Moccaldi
376 [GO] 2020―Dec―11 PMU7 Efficiency-Based Protocols for BEDS Evacuation during the COVID-19 Pandemic T. Nepomuceno, W.M.D.N. Silva, L.G.D.O. Silva
377 [GO] 2020―Dec―11 PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic K. Athanasakis, N. Nomikos, K. Souliotis, J. Kyriopoulos
378 [GO] 2020―Dec―11 PNS126 Simpli - a Capacity Simulator for Evaluating Measures to Reduce the Backlog of Hospital Services after the COVID-19 Pandemic C. Bandeiras, F. Oliveira, M. Mota, R. Moita Fidalgo, A. Oliveira, C. Franco, et al. (+4)
379 [GO] 2020―Dec―11 PUK21 The VALUE of a Sustainable and Resilient Technical Service Network and Its Importance in Times of the COVID-19 Pandemic C. Hornig, E. Busink, B. Lababidi, M. Luckau, T. Pohl, C. Mutz
380 [GO] 2020―Dec―11 SP3 Should I Choose Artificial Intelligence or Clinicians' Diagnosis? a Discrete Choice Experiment of Patients' Preference UNDER COVID-19 Pandemic in China T. Liu, W. Tsang, F. Huang, W.K. Ming
381 [GO] 2020―Dec―11 PIN49 Influenza Vaccination and Its IMPACT on the Availability Intensive Care Unit BEDS during the COVID-19 Pandemic in Colombia M. Pareja, S. Londono, M. Moreno
382 [GO] 2020―Dec―11 PCV78 Clinical Pharmacists Assistance during COVID-19 Pandemic in Patients with ACUTE Coronary Syndrome at a Tertiary Care Hospital in India. O. Gona, R. Madhan
383 [GO] 2020―Dec―11 PIN154 QALY Losses Attributable to COVID-19 Pandemic in Spain V. Hernando, M. Brosa
384 [GO] 2020―Dec―11 PMU85 IMPACT of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B. Halioua, J. Zetlaoui, A. Astruc, T. Lévy-Heidmann, D. Testa, A. Bombezin--Domino, L. Radoszycki
385 [GO] 2020―Dec―11 PMU109 IMPACT of the COVID-19 Pandemic on Patients with Immune-Mediated Inflammatory Diseases Taking a Biologic Therapy B. Halioua, J. Zetlaoui, A. Astruc, D. Testa, A. Bombezin--Domino, L. Radoszycki
386 [GO] 2020―Dec―11 PMH25 The IMPACT of the COVID-19 Pandemic on the Mental Health of US Adults: A CROSS-Sectional Study A. Morlock, R. Morlock, S. Holmstrom
387 [GO] 2020―Dec―11 PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis W. Padula, S. Malaviya, N. Reid, F. Chingcuanco, J. Ballreich, J. Tierce, G.C. Alexander
388 [GO] 2020―Dec―11 PCN216 An Innovative Organization MODEL to Face Risks Reduction Challenges in an Italian Cancer Center during the COVID-19 Pandemic: A Risk Reduction Estimation Study N. Gentili, A. Roncadori, I. Massa, C. Florescu, L. Bertoni, F. Galardi, et al. (+7)
389 [GO] 2020―Dec―11 PCN353 Oncology Treatments during COVID-19 Pandemic: IMPACT in a Health Care PLAN in Brazil J.P. Reis Neto, J. Busch
390 [GO] 2020―Dec―11 PNS116 Maintaining Routine Healthcare for Chronic Medical Conditions during the COVID-19 Pandemic: What WE CAN Learn from Australia Z.M. Thet Lwin, T.C. Higgins, K. Winn, K.H. Naing
391 [GO] 2020―Dec―11 PIN8 A MODEL for Estimation of Possible COVID-19 Patient Numbers in Turkey S. Öztopçu, E.B. Karahan, S. Ökçün, M. Kurnaz, G. Oğuzhan, Z. Caliskan, G. Kockaya
392 [GO] 2020―Dec―11 PDB45 Obesity: A Major Risk Factor for Adverse Outcomes Among Young COVID-19 Patients R. Kashambwa, Z. Drebert
393 [GO] 2020―Dec―11 PIN108 Using the Apriori Algorithm to Identify Risk Factors Associated with Survival and Mortality Among COVID-19 Patients A. Vashisht, C. Holy, S. Shah, N. Elangovanraaj, S. Johnston, P. Coplan
394 [GO] 2020―Dec―11 PIN171 A Real-World DATA Analysis of Mortality and Heart Arrhythmia Risk in Hospitalized COVID-19 Patients Treated with Hydroxychloroquine Z. Drebert, R. Kashambwa
395 [GO] 2020―Dec―11 PIN56 Cost of COVID-19 Patients Treatment in Turkey E.B. Karahan, S. Öztopçu, M. Kurnaz, S. Ökçün, Z. Caliskan, G. Oğuzhan, G. Kockaya
396 [GO] 2020―Dec―11 ML4 Application of Machine Learning Models to Evaluate COVID-19 Related ICU Utilization in a US Population Z. Icten, C. Chan, M. Munsell, J. Menzin
397 [GO] 2020―Dec―11 PNS198 Arogya Setu Mobile Application for COVID-19 Self-Assessment, Education and Participatory Disease Surveillance: Perception Among Medical and Technology University Students. J. Kochuparambil, A. Nidha
398 [GO] 2020―Dec―11 PUK20 Reimbursement Landscape in Europe As Hurdle or Accelerator of HOME Hemodialysis in COVID-19 Times E. Busink, J. Petrovic, D. Kendzia, S. Boeger, C. Apel
399 [GO] 2020―Dec―11 PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population M. Costa, P. Net, D. Proshenska, F. Bianic, F. Guelfucci
400 [GO] 2020―Dec―11 PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population P. Net, M. Costa, D. Proshenska, F. Bianic, F. Guelfucci
401 [GO] 2020―Dec―11 PNS206 Projecting the COVID-19 Weekly Deaths and Hospitalizations for Jefferson County, Kentucky P. Naiya
402 [GO] 2020―Dec―11 PIN3 Chloroquine and Hydroxychloroquine in COVID-19 with or without Azithromycin: A Systematic Review of in Vitro and Clinical Studies M. Jameleddine, N. Harzallah, H. Grati, M.C. Jebali, C. Hamouda
403 [GO] 2020―Dec―11 PMU82 Increasing Importance of Digital CME in a Post COVID-19 World N. Eslami, K. Infante, B. Harris, G. Erickson, C. Hoyvald, S. Garfield
404 [GO] 2020―Dec―11 PMU5 The Future of Market Access in a Post COVID-19 World - What Do WE Need to Do Differently? C. Teale, S. Morrison, R. Zeidman, R. Tolley, L. Flemingq
405 [GO] 2020―Dec―11 PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives K. Skaltsa, C. Ivanescu, M. Reaney
406 [GO] 2020―Dec―11 PIN110 Socioeconomic Factors Impacting COVID-19-Related Mortality in the United States E. Ridgway, N. Savant, G. Pauletti, J.A. Pieper, P. Juang
407 [GO] 2020―Dec―11 PMU59 The IMPACT of COVID-19: A Comparison of the Number of Regulatory and Health Technology Assessments between the First SIX Months of 2019 and 2020 M. Salvador, K.E. Young
408 [GO] 2020―Dec―11 PIN70 Knowledge Towards Universal Safety Precautions Among Healthcare Population in India during Initial Phase of COVID-19: A Web Based Survey J. Kochuparambil, A. Issac, S. George, N.K. Panicker
409 [GO] 2020―Dec―11 PRS81 Insights into the Coronavirus Disease Perceptions in Pakistan W. Ullah, H. Almansour, G. Victor, S. Hussain, A.J. Pienaar
410 [GO] 2020―Dec―11 CL4 Concerns, Quality of Life, Access to Care and Productivity of the General Population during the First 8 WEEKS of the Coronavirus Lockdown in Belgium and the Netherlands R. Michels, L.M.A. Goossens, R. Bruin, H. van Ballegooijen, M. Krol
411 [GO] 2020―Dec―11 PIN153 Lessons Learned from Economic Models of Influenza Vaccines and Applications to SARS-CoV-2 J. Benner, N. Adair, M. Friedman, J. Menzin, M. Sussman
412 [GO] 2020―Dec―11 PMU28 Multimodal Strategy to Control and Mitigate a Sars-COV-2 Epidemic Outbreak in the Emergency Service of Highly Complex Hospital in Santiago De Chile M. Galvez, J. Retamal, M. Chepo, K. Mondaca, C. Silva, N. Febré
413 [GO] 2020―Dec―11 PRS65 US Sars-COV-2 Geospatial Predictive Weather Mapping MODEL: Application of Machine Learned Bayesian Networks to Healthcare Decision Making J. Vanderpuye-Orgle, D. Erim, M. Maruszczak, S. Pandey, A. Shields, M. Keywood, et al. (+2)
414 [GO] 2020―Dec―11 PIN71 Comparison of Seasonality of Common Viral and Respiratory Diseases VS Emergence of Sars-COV-2 Infection D. Krishnan, C. Holy, S. Shah, N. Elangovanraaj, S. Gupta, P. Trivedi, et al. (+3)
415 [GO] 2020―Dec―11 PIN74 The Impact of Social Distancing on Sars-COV-2 Mortality: A US Analysis A. Gurubaran, C. Holy, S. Shah, B. Nandi, H. Dwarakanathan, A. Bhardwaj, et al. (+2)
416 [GO] 2020―Dec―11 PIN115 Understanding Sars-COV-2 Mortality: IMPACT of Population and Mobility Metrics S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
417 [GO] 2020―Dec―11 PIN111 Predicting the Decline in Sars-COV-2 New Infections: A Modelling Analysis of US Counties H. Dwarakanathan, O. Kakade, A. Bhardwaj, C. Holy, A. Gurubaran, S. Shah, P. Coplan
418 [GO] 2020―Dec―11 PRS58 IMPACT of Sars-COV-2 on Provided Healthcare. Evidence from the Emergency Phase in Italy. R. Di Bidino, A. Cicchetti
419 [GO] 2020―Dec―11 CO4 An Evaluation of the Differences in Vaccine Approval and Procurement Processes between Healthcare Systems during a Pandemic A. Robert, J. Farrington, L. Longworth
420 [GO] 2020―Dec―11 PIN145 Online- Education in Times of Pandemic a Strategy That Allows Change in Times of Crisis, an Example in Chile. N. Febré, V. Nasabun Flores, M.V. Badilla, S. Contreras, T. Pavlov, L.R. Diaz-Diaz, P. Ivanovic
421 [GO] 2020―Dec―11 PR3 Patient-Reported Outcome Measures to Prioritize Surgical Lists during Pandemic Events S. De Rosis, D.A. Lungu, F. Pennucci, S. Nuti
422 [GO] 2020―Dec―11 PCV81 Virtual Anticoagulation Clinic Care a Telehealth MODEL to Deliver Continuity of Anticoagulation Care during the COVID 19 Pandemic: Insights from Southern India O. Gona, S.K. S, R. Madhan
423 [GO] 2020―Dec―10 Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis Amir Shlomai, Ari Leshno, Ella H. Sklan, Moshe Leshno
424 [GO] 2020―Oct―13 The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19) C. Daniel Mullins, Michael F. Drummond
425 [GO] 2020―Oct―05 Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group Joy Leahy, Conor Hickey, David McConnell, Owen Cassidy, Lea Trela-Larsen, Michael Barry, et al. (+2)
426 [GO] 2020―Sep―06 Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations Dalia M Dawoud, Khaled Y Soliman
427 [GO] 2020―Sep―04 Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study Shelby Reed, Juan Marcos Gonzalez, F. Reed Johnson
428 [GO] 2020―Aug―27 Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the UK Darshan Zala, Iris Mosweu, Simone Critchlow, Renee Romeo, Paul McCrone
429 [GO] 2020―Jul―27 Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China Siyu Ma, David D. Kim, Joshua T. Cohen, Peter J. Neumann
430 [GO] 2020―May―21 The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable Steven Forsythe, Joshua Cohen, Peter Neumann, Stefano M. Bertozzi, Anthony Kinghorn

430 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.174 sec